Jeffrey M. Lipton, MD, PhD
Chief, Hematology/Oncology and Stem Cell Transplantation
Steven and Alexandra Cohen Children’s Medical Center of New York
New Hyde Park, New York
Jeffrey M. Lipton, M.D., Ph.D. is currently the chief of hematology/oncology and stem cell transplantation at the Steven and Alexandra Cohen Children’s Medical Center of New York, New Hyde Park, NY; center head, patient-oriented research, The Feinstein Institute for Medical Research professor, Elmezzi Graduate School of Molecular Medicine, The Feinstein Institute for Medical Research; and professor of pediatrics and molecular medicine at the Hofstra North Shore – LIJ School of Medicine. He holds a B.A. from Queens College, City University of New York. He received a doctoral degree in chemistry from Syracuse University and his medical degree, magna cum laude, from Saint Louis University Medical School. He did his pediatric training at the Children’s Hospital, Boston, MA, and his pediatric hematology/oncology fellowship training at the Children’s Hospital and the Dana-Farber (née Sidney Farber) Cancer Institute in Boston. Prior to joining the Hofstra North Shore-LIJ School of Medicine he was a professor of pediatrics at the Albert Einstein College of Medicine in New York.
Dr. Lipton is the immediate past-president (2010-2012) of the American Society of Pediatric Hematology/Oncology (ASPHO) and recipient of the 2010 Saint Louis University’s School of Medicine Alumni Merit Award. Dr. Lipton’s interests focus on the rare inherited bone marrow failure syndromes. He currently directs the translational program devoted to understanding the genetics, cellular and molecular biology of Diamond Blackfan anemia (DBA) and in particular malignant predisposition and birth defects observed in patients with DBA. His lab was the first to describe Diamond Blackfan anemia as a disorder of proapoptotic erythropoiesis. He is an author of over 170 original articles, reviews and book chapters.